Document Detail


U.S. blocks trade agreement on generic drug access in poor countries.
MedLine Citation:
PMID:  12569874     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Governments can override patents for legitimate purposes, including public health. But many small or poor countries hve no pharmaceutical industry to manufacture medicines themselves, and global trade rules being phased in will prevent others from exporting to them without the patent holder's permission. Negotiations to solve this problem broke down when the U.S. insisted that any agreement apply only to AIDS, tuberculosis, malaria, and similar major epidemics--excluding cancer, heart disease, and hundreds of other diseases.
Authors:
John S James
Related Documents :
5784114 - Heart sound screening in high, low and middle income communities.
7278204 - Fourier analysis of isolated rat heart electrocardiographs as a measure of viability af...
10799424 - Anthropometric indices of failure to thrive.
7479814 - A perspective on early commercial applications of voice-processing technology for telec...
8337744 - Demographic entrapment.
Publication Detail:
Type:  Newspaper Article    
Journal Detail:
Title:  AIDS treatment news     Volume:  -     ISSN:  1052-4207     ISO Abbreviation:  AIDS Treat News     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2003-01-26     Completed Date:  2003-02-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8809835     Medline TA:  AIDS Treat News     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4-6     Citation Subset:  X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Commerce / legislation & jurisprudence*
Developing Countries*
Drugs, Generic / supply & distribution*
Health Services Accessibility*
Patents as Topic
United States
Chemical
Reg. No./Substance:
0/Drugs, Generic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effects of jianpizengmian granule on tumor growth and immune function
Next Document:  Update on antiretroviral drug resistance testing: combining laboratory technology with patient care.